• Vaccines
What we’re working on
Our COVID-19 vaccine is leveraging the accelerated vaccine roadmap for pandemic response, and is in Phase 1 and 2 clinical trials.
Our Universal Coronavirus vaccine is under development, to protect against both known and unknown strains of Coronavirus.
These vaccine candidates complement mRNA vaccines, enabling broader applicability and impact.
• Vaccines
Lab to market
We need faster, more cost effective and, most importantly, highly accessible approaches to vaccine development and distribution.
Our in-development lab-to-market framework will feature self-administered vaccines and therapeutics available both online and through physical pharmacy and urgent-care centers.
• Vaccines
Delivery mechanisms
At Nano, we have a deep admiration and respect for the history of vaccine development, but we’re not confined by conventional ideas about distribution.
While vaccines will continue to be delivered via the traditional ‘shot’, our vision includes application methods like those of everyday pharmacy medications; for example: vaccination delivered via topical creams or a nasal spray similar to products currently on the market for common medical complaints.
• Vaccines
Delivery mechanisms
At Nano, we have a deep admiration and respect for the history of vaccine development, but we’re not confined by conventional ideas about distribution.
While vaccines will continue to be delivered via the traditional ‘shot’, our vision includes application methods like those of everyday pharmacy medications; for example: vaccination delivered via topical creams or a nasal spray similar to products currently on the market for common medical complaints.